1
|
Thanigachalam S, Pathak M. Bioactive O^N^O^ Schiff base appended homoleptic titanium(iv) complexes: DFT, BSA/CT-DNA interactions, molecular docking and antitumor activity against HeLa and A549 cell lines. RSC Adv 2024; 14:13062-13082. [PMID: 38655487 PMCID: PMC11034360 DOI: 10.1039/d3ra08574k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2023] [Accepted: 04/06/2024] [Indexed: 04/26/2024] Open
Abstract
Five new homoleptic derivatives of titanium(iv) have been developed and characterized by physicochemical techniques. Metal complexes, TiH2L1 [(C38H26N6O4)Ti], TiH2L2 [(C38H24F2N6O4)Ti], TiH2L3 [(C38H24Cl2N6O4)Ti], TiH2L4 [(C38H24Br2N6O4)Ti] and TiH2L5 [(C38H24N8O8)Ti], were obtained by treating Ti(OPri)4 with appropriate ONO ligands (H2L1-H2L5) in anhydrous THF as solvent. The electronic structures and properties of titanium(iv) complexes (TiH2L1-TiH2L5) and ligands (H2L1-H2L5) were examined by DFT studies. The stability of all synthesized derivatives was assessed by a UV-visible technique using 10% DMSO, GSH medium and n-octanol/water systems. The binding interactions of BSA and CT-DNA with respective titanium(iv) complexes were successfully evaluated by employing UV-visible absorption, fluorescence, circular dichroism (CD) techniques and docking studies. The in vitro cytotoxicity of TiH2L2, TiH2L3 and TiH2L4 complexes was assessed against HeLa (human epithelioid cervical cancer cells) and A549 (lung carcinoma) cell lines. The IC50 values of TiH2L2, TiH2L3 and TiH2L4 were observed to be 28.8, 14.7 and 31.2 μg mL-1 for the HeLa cell line and 38.2, 32.9 and 67.78 μg mL-1 for A549 cells, respectively. Complex TiH2L3 exhibited remarkably induced cell cycle arrest in the G1 phase and 77.99% ROS production selectivity in the HeLa cell line.
Collapse
Affiliation(s)
- Sathish Thanigachalam
- Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology Vellore 632014 Tamilnadu India
| | - Madhvesh Pathak
- Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology Vellore 632014 Tamilnadu India
| |
Collapse
|
2
|
Hipólito J, Martins AM, Alves LG. Synthesis and Application of New Salan Titanium Complexes in the Catalytic Reduction of Aldehydes. Molecules 2022; 27:molecules27206821. [PMID: 36296413 PMCID: PMC9610537 DOI: 10.3390/molecules27206821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Revised: 10/04/2022] [Accepted: 10/08/2022] [Indexed: 11/16/2022] Open
Abstract
Complexes of formula [(H2N2O2)TiCl2] and [(H2N2O2)Ti(OiPr)2] (H2N2O2H2 = HOPh’CH2NH(CH2)2NHCH2Ph’OH, where Ph’ = 2,4-(CMe2Ph)C6H2) were synthesized by the reaction of the salan ligand precursor H2N2O2H2 with TiCl4 and Ti(OiPr)4, respectively, in high yields. The dichlorido complex [(H2N2O2)TiCl2] revealed to be an efficient catalyst for the reduction of benzaldehyde in toluene. Full conversion was observed after 24 h at 55 °C in THF. The same catalyst also converted phenylacetaldehyde and hydrocinnamaldehyde into the corresponding alkanes quantitatively.
Collapse
Affiliation(s)
- Joana Hipólito
- Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal
| | - Ana M. Martins
- Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal
- Correspondence: (A.M.M.); (L.G.A.)
| | - Luis G. Alves
- Centro de Química Estrutural, Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Av. Rovisco Pais 1, 1049-003 Lisboa, Portugal
- Correspondence: (A.M.M.); (L.G.A.)
| |
Collapse
|
3
|
Miller M, Mellul A, Braun M, Sherill-Rofe D, Cohen E, Shpilt Z, Unterman I, Braitbard O, Hochman J, Tshuva EY, Tabach Y. Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug. iScience 2020; 23:101262. [PMID: 32585595 PMCID: PMC7322074 DOI: 10.1016/j.isci.2020.101262] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2020] [Revised: 05/07/2020] [Accepted: 06/05/2020] [Indexed: 12/23/2022] Open
Abstract
PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first genome study on Ti(IV)-treated cells, using an attuned RNA sequencing-based available technology. First, phenolaTi induced apoptosis and cell-cycle arrest at the G2/M phase in MCF7 cells. Second, the transcriptome of the treated cells was analyzed, identifying alterations in pathways relating to protein translation, DNA damage, and mitochondrial eruption. Unlike for common metallodrugs, electrophoresis assay showed no inhibition of DNA polymerase activity. Reduced in vitro cytotoxicity with added endoplasmic reticulum (ER) stress inhibitor supported the ER as a putative cellular target. Altogether, this paper reveals a distinct ER-related mechanism by the Ti(IV) anticancer coordination complex, paving the way for wider applicability of related techniques in mechanistic analyses of metallodrugs.
Collapse
Affiliation(s)
- Maya Miller
- Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel; Department of Developmental Biology and Cancer Research, Institute of Medical Research-Israel-Canada, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel
| | - Anna Mellul
- Department of Developmental Biology and Cancer Research, Institute of Medical Research-Israel-Canada, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel
| | - Maya Braun
- Department of Developmental Biology and Cancer Research, Institute of Medical Research-Israel-Canada, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel
| | - Dana Sherill-Rofe
- Department of Developmental Biology and Cancer Research, Institute of Medical Research-Israel-Canada, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel
| | - Emiliano Cohen
- Department of Developmental Biology and Cancer Research, Institute of Medical Research-Israel-Canada, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel
| | - Zohar Shpilt
- Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel
| | - Irene Unterman
- Department of Developmental Biology and Cancer Research, Institute of Medical Research-Israel-Canada, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel
| | - Ori Braitbard
- Department of Cell and Developmental Biology, Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel
| | - Jacob Hochman
- Department of Cell and Developmental Biology, Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel
| | - Edit Y Tshuva
- Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
| | - Yuval Tabach
- Department of Developmental Biology and Cancer Research, Institute of Medical Research-Israel-Canada, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
| |
Collapse
|
4
|
Engelberg N, Bino A, Tshuva EY. Preparation, structural characterization and cytotoxicity of hydrolytically stable Ti(IV) citrate complexes. Inorganica Chim Acta 2020. [DOI: 10.1016/j.ica.2020.119429] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
5
|
Sha F, Shimizu EA, Slocumb HS, Towell SE, Zhen Y, Porter HZ, Takase MK, Johnson AR. Catalytic intramolecular hydroamination of aminoallenes using titanium and tantalum complexes of sterically encumbered chiral sulfonamides. Dalton Trans 2020; 49:12418-12431. [DOI: 10.1039/d0dt02557g] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Titanium and tantalum catalysts supported by readily prepared chiral sulfonamide ligands catalyze hydroamination of aminoallenes that lack N-protecting groups.
Collapse
Affiliation(s)
| | | | | | | | - Yi Zhen
- Harvey Mudd College
- Claremont
- USA
| | | | | | | |
Collapse
|
6
|
Abid M, Nouch R, Bradshaw TD, Lewis W, Woodward S. Tripodal O-N-O Bis
-Phenolato Amine Titanium(IV) Complexes Show High in vitro Anti-Cancer Activity. Eur J Inorg Chem 2019. [DOI: 10.1002/ejic.201900510] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Affiliation(s)
- Mohammed Abid
- Department of Chemistry; College of Science; University of Anbar; Western side of Ramadi City Anbarshire Republic of Iraq
- GSK Carbon Neutral Laboratories for Sustainable Chemistry; University of Nottingham; Triumph Road Nottingham NG7 2TU United Kingdom
| | - Ryan Nouch
- GSK Carbon Neutral Laboratories for Sustainable Chemistry; University of Nottingham; Triumph Road Nottingham NG7 2TU United Kingdom
| | - Tracey D. Bradshaw
- School of Pharmacy, Centre for Biomolecular Sciences; College of Science; University Park Nottingham NG7 2RD United Kingdom
| | - William Lewis
- GSK Carbon Neutral Laboratories for Sustainable Chemistry; University of Nottingham; Triumph Road Nottingham NG7 2TU United Kingdom
| | - Simon Woodward
- GSK Carbon Neutral Laboratories for Sustainable Chemistry; University of Nottingham; Triumph Road Nottingham NG7 2TU United Kingdom
| |
Collapse
|
7
|
Miller M, Tshuva EY. Racemic vs. enantiopure inert Ti(iv) complex of a single diaminotetrakis(phenolato) ligand in anticancer activity toward human drug-sensitive and -resistant cancer cell lines. RSC Adv 2018; 8:39731-39734. [PMID: 30713687 PMCID: PMC6333245 DOI: 10.1039/c8ra08925f] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2018] [Accepted: 11/21/2018] [Indexed: 12/16/2022] Open
Abstract
A tetrakis(phenolato) Ti(iv) complex was synthesized in racemic and optically pure form, exhibiting high hydrolytic stability, and similar cytotoxicity for all stereochemical forms on HT-29 and A2780 cancer cells. Higher activity of the racemate on drug-resistant A2780cp and A2780adr lines implies a beneficial activity of both enantiomers rendering enantiomeric resolution unnecessary.
Collapse
Affiliation(s)
- Maya Miller
- Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
| | - Edit Y Tshuva
- Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
| |
Collapse
|